Storia in 17 fonti

An AstraZeneca-Bristol Myers megamerger? Wall Street isn’t thrilled.

In fact, the former lost tens of billions of dollars in market value following reports of a potential tie-up between the pharmaceutical giants.

Raccontata da

cityam.com+5 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

biopharmadive.comStai leggendo1 g fa

An AstraZeneca-Bristol Myers megamerger? Wall Street isn’t thrilled.

AstraZeneca and Bristol Myers discussed a $400 billion megamerge, but investor backlash sent AZ down 8%, erasing $22 billion in value. The deal signals pharma shifting to transformational M&A from bolt-on acquisitions, reshaping industry consolidation playbooks.

originale

Timeline cronologica

domenica 2 agosto 2026·handelsblatt.com
Pharma: AstraZeneca erwägt Mega-Fusion mit US-Rivalen Bristol Myers Squibb
Es wäre eine der größten Fusionen in der Wirtschaftsgeschichte. Laut einem Medienbericht wurden entsprechende Gespräche geführt. Ob es zu einem Zusammenschluss kommt ist jedoch…
domenica 2 agosto 2026·cnbc.com
AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports
U.K. pharmaceutical giant AstraZeneca is considering a deal to merge with its U.S. rival Bristol Myers Squibb.

An AstraZeneca-Bristol Myers megamerger? Wall Street isn’t thrilled.

Confronto fonti

An AstraZeneca-Bristol Myers megamerger? Wall Street isn’t thrilled.

Timeline cronologica

Pharma: AstraZeneca erwägt Mega-Fusion mit US-Rivalen Bristol Myers Squibb

AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

AstraZeneca Stock Nosedives On Mega-Merger Rumor

AstraZeneca-Bristol Myers megamerger talk leaves Wall Street wanting more answers

AstraZeneca shares fall amid reports of $400bn Bristol Myers Squibb merger talks

AstraZeneca said to have explored Bristol Myers merger | Fortune

Pharma giants AstraZeneca and Bristol-Myers in reported merger talks

Pharma giants AstraZeneca, Bristol Myers Squibb in talks on $512 billion megadeal: Report

AstraZeneca, Bristol Myers Squibb Reportedly in Talks for $400 Billion Merger - AstraZeneca (NYSE:AZN)

AstraZeneca, Bristol Myers are in talks about merger — report

AstraZeneca said to have explored Bristol Myers merger | Fortune

An AstraZeneca-Bristol Myers megamerger? Wall Street isn’t thrilled.

La potentielle fusion avec Bristol-Myers Squibb fait plonger AstraZeneca - Le Temps

Ft: AstraZeneca tratta con Bristol Myers Squibb fusione da 400 mld

Pharma: Astra-Zeneca erwägt wohl Mega-Fusion mit Bristol-Myers Squibb

AstraZeneca: Pharmakonzern prüft 400-Milliarden-Dollar-Fusion mit Bristol Myers

AstraZeneca Held Talks to Combine With Bristol Myers Squibb, FT Says, Citing Sources

Astrazeneca explores $400bn megadeal with US rival

AstraZeneca in talks over £300bn mega-merger with US rival – reports

AstraZeneca shares drop 7% after report on $400 billion merger talks with Bristol Myers Squibb

AstraZeneca, BMS discuss $400B pharma mega-deal

AstraZeneca ‘in talks to create £300bn pharmaceutical giant’

Astrazeneca giù a Londra, per Ft tratta una mega-fusione con Bristol Myers Squibb

AstraZeneca pensa alla fusione con Bristol Myers Squibb: possibile colosso da 400 miliardi

Pharma: Mega-Fusion zwischen Astra Zeneca und Bristol Myers im Gespräch